269 related articles for article (PubMed ID: 27918712)
41. Early versus late initiation of rehabilitation after lumbar spinal fusion: economic evaluation alongside a randomized controlled trial.
Oestergaard LG; Christensen FB; Nielsen CV; Bünger CE; Fruensgaard S; Sogaard R
Spine (Phila Pa 1976); 2013 Nov; 38(23):1979-85. PubMed ID: 23928716
[TBL] [Abstract][Full Text] [Related]
42. Economic evaluation of a combined screening and stepped-care treatment program targeting psychological distress in patients with metastatic colorectal cancer: A cluster randomized controlled trial.
El Alili M; Schuurhuizen CSEW; Braamse AMJ; Beekman ATF; van der Linden MH; Konings IR; Dekker J; Bosmans JE
Palliat Med; 2020 Jul; 34(7):934-945. PubMed ID: 32348700
[TBL] [Abstract][Full Text] [Related]
43. Economic evaluation of an intensive group training protocol compared with usual care physiotherapy in patients with chronic low back pain.
van der Roer N; van Tulder M; van Mechelen W; de Vet H
Spine (Phila Pa 1976); 2008 Feb; 33(4):445-51. PubMed ID: 18277878
[TBL] [Abstract][Full Text] [Related]
44. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
[TBL] [Abstract][Full Text] [Related]
45. Randomized trial of two physiotherapy interventions for primary care back and neck pain patients: cost effectiveness analysis.
Manca A; Dumville JC; Torgerson DJ; Klaber Moffett JA; Mooney MP; Jackson DA; Eaton S
Rheumatology (Oxford); 2007 Sep; 46(9):1495-501. PubMed ID: 17711873
[TBL] [Abstract][Full Text] [Related]
46. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
[TBL] [Abstract][Full Text] [Related]
48. Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction.
Bøhmer E; Kristiansen IS; Arnesen H; Halvorsen S
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):717-23. PubMed ID: 21450598
[TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of an improving access to psychological therapies service.
Mukuria C; Brazier J; Barkham M; Connell J; Hardy G; Hutten R; Saxon D; Dent-Brown K; Parry G
Br J Psychiatry; 2013 Mar; 202(3):220-7. PubMed ID: 23307921
[TBL] [Abstract][Full Text] [Related]
50. Effectiveness and cost-effectiveness of adding a cognitive behavioral treatment to the rehabilitation of chronic low back pain.
Schweikert B; Jacobi E; Seitz R; Cziske R; Ehlert A; Knab J; Leidl R
J Rheumatol; 2006 Dec; 33(12):2519-26. PubMed ID: 17143986
[TBL] [Abstract][Full Text] [Related]
51. An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis.
de Kinderen RJ; Lambrechts DA; Wijnen BF; Postulart D; Aldenkamp AP; Majoie MH; Evers SM
Epilepsia; 2016 Jan; 57(1):41-50. PubMed ID: 26617284
[TBL] [Abstract][Full Text] [Related]
52. Cost-effectiveness of a short stay admission programme for breast cancer surgery.
de Kok M; Dirksen CD; Kessels AG; van der Weijden T; van de Velde CJ; Roukema JA; Bell AV; van der Ent FW; von Meyenfeldt MF
Acta Oncol; 2010 Apr; 49(3):338-46. PubMed ID: 20397768
[TBL] [Abstract][Full Text] [Related]
53. The economic burden of depression in Sweden from 1997 to 2005.
Sobocki P; Lekander I; Borgström F; Ström O; Runeson B
Eur Psychiatry; 2007 Apr; 22(3):146-52. PubMed ID: 17194573
[TBL] [Abstract][Full Text] [Related]
54. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
55. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
56. Head and neck cancer patients want us to support them psychologically in the posttreatment period: Survey results.
Henry M; Habib LA; Morrison M; Yang JW; Li XJ; Lin S; Zeitouni A; Payne R; MacDonald C; Mlynarek A; Kost K; Black M; Hier M
Palliat Support Care; 2014 Dec; 12(6):481-93. PubMed ID: 24153040
[TBL] [Abstract][Full Text] [Related]
57. Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: an economic evaluation alongside a pragmatic randomized controlled trial.
Albers-Heitner CP; Joore MA; Winkens RA; Lagro-Janssen AL; Severens JL; Berghmans LC
Neurourol Urodyn; 2012 Apr; 31(4):526-34. PubMed ID: 22275126
[TBL] [Abstract][Full Text] [Related]
58. The 3-Year Cost-Effectiveness of a Nurse-Based Case Management versus Usual Care for Elderly Patients with Myocardial Infarction: Results from the KORINNA Follow-Up Study.
Seidl H; Hunger M; Meisinger C; Kirchberger I; Kuch B; Leidl R; Holle R
Value Health; 2017 Mar; 20(3):441-450. PubMed ID: 28292489
[TBL] [Abstract][Full Text] [Related]
59. Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.
Schuurhuizen CSEW; Braamse AMJ; Beekman ATF; Cuijpers P; van der Linden MHM; Hoogendoorn AW; Berkhof H; Sommeijer DW; Lustig V; Vrijaldenhoven S; Bloemendal HJ; van Groeningen CJ; van Zweeden AA; van der Vorst MJDL; Rietbroek R; Tromp-van Driel CS; Wymenga MNW; van der Linden PW; Beeker A; Polee MB; Batman E; Los M; van Bochove A; Brakenhoff JAC; Konings IRHM; Verheul HMW; Dekker J
J Natl Compr Canc Netw; 2019 Aug; 17(8):911-920. PubMed ID: 31390590
[TBL] [Abstract][Full Text] [Related]
60. Cost-Effectiveness Analysis of Percutaneous Sclerotherapy for Venous Malformations.
Ono Y; Osuga K; Takura T; Nakamura M; Shibamoto K; Yamamoto A; Fujiwara H; Mimura H; Tomiyama N
J Vasc Interv Radiol; 2016 Jun; 27(6):831-7. PubMed ID: 26972615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
